PLCG2 and colorectal carcinoma: The results showed that CRC patients with high expression of PLCG2 had more infiltration of Treg cells (FOXP3+CD4+) and less infiltration of CD8+ T cells (CD3+CD8A+) in the TME compared to those with low expression of PLCG2 (Figure 9A, C).